Psychiatry & Neurology Doctors in Monmouth Beach, NJ Accepting Medicare

1 Psychiatry & Neurology doctors found. Showing 1 - 1

Dr. Norbert James Binkowski, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 45 Ocean Ave, Monmouth Beach, NJ 07750 Phone: 732-229-7195    Fax: 732-774-4061

News Archive

Examining NTD response in Obama's second term

"As President Obama's second term begins to take shape and new faces assume new leadership roles, many in Washington are trying to gauge what will happen to global health," Michelle Brooks, policy director at the Global Network for Neglected Tropical Diseases (NTDs), writes in the organization's "End the Neglect" blog.

ChemGenex Pharmaceuticals to present updated clinical data from its clinical trials with Omapro

ChemGenex Pharmaceuticals Limited announced today that updated clinical data from several of its clinical trials with Omapro™ (omacetaxine mepesuccinate) will be presented at the upcoming 51st American Society of Hematology Annual Meeting in New Orleans, Louisiana.

Procter & Gamble 2010 first quarter net sales increases 2% to $20.1 billion

The Procter & Gamble Company reported first quarter diluted net earnings per share from continuing operations of $1.02 per share, an increase of five percent and above the Company's guidance range of $0.97 to $1.01.

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms

GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not been established.

XIFIN joins PMC to help evolve reimbursement policies and practices that support personalized medicine

XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, has joined the Personalized Medicine Coalition, an educational and advocacy group dedicated to advancing the understanding and adoption of personalized medicine, defined as the application of genomic and molecular data to better target the delivery of healthcare by determining a person's predisposition to a particular disease or condition.

Read more Medical News

› Verified 8 days ago